Gregory J. Divis, Chief Executive Officer at AVADEL PHARMACEUTICALS PLC (AVDL), bought 10,000 shares at $13.20 ($132K) on 2023-08-10, disclosed to the SEC on 2023-08-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| AVDL | BUY | 2020-08-13 | $101K | — | Filing → |